Nov 30, 2023

Are you on the board of directors of a company? A shareholder of a publicly traded one? A CEO or CFO who reports to a board? This episode is for you. Following up on last week’s conversation with Mark Cuban (EP418), Stacey Richter talks with Andreas Mang, senior managing director and CEO of Equity Healthcare at...

Nov 23, 2023

“The Achilles’ heel for most healthcare innovators is overlooking the role of change management,” as a recent tweet from Rik Renard put it — the deal isn’t sealed until the whole team is on board, and adoption never automatically follows a good idea. Stacey Richter is re-airing this conversation with Karen...

Nov 16, 2023

Healthcare benefits are usually a company’s second-biggest line-item expense after payroll, yet most CEOs and CFOs never actually dig into where that money goes. In this episode, Stacey Richter talks with Mark Cuban and Ferrin Williams, PharmD, MBA, chief pharmacy officer at Scripta, about what happened when...

Nov 9, 2023

A physician practice can only truly transform from a fee-for-service volume machine into something built around health and value once it hits a tipping point: enough of its patients in value-based, risk-based arrangements to make accountability actually feasible. Self-insured employers, who cover roughly 150 million...

Nov 2, 2023

Most payer-provider relationships aren’t collaborative — they’re fairly adversarial, especially from the standpoint of provider organizations trying to find a payment model that lets them actually do right by patients. In this episode, Stacey Richter talks with Josh Berlin, JD, CEO of Rule of Three, about the...